E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/5/2015 in the Prospect News Emerging Markets Daily, Prospect News High Yield Daily, Prospect News Municipals Daily, Prospect News Preferred Stock Daily and Prospect News Private Placement Daily.

Merck upsizes jumbo deal; Japan Finance, Costco price; Pfizer, Hospira active on acquisition

By Aleesia Forni

Virginia Beach, Feb. 5 – The investment-grade primary saw Merck & Co., Inc. come to market with a jumbo bond offering during the session on Tuesday, helping push the week’s new issuance total past expectations.

The massive $8 billion deal met with solid demand, allow the underwriters to increase the amount from initial size thoughts of $6 billion.

All six tranches of the offering sold at the tight end of talk.

In other primary happenings, Japan Finance Organization for Municipalities and Costco Wholesale Corp. were each in the primary with $1 billion offerings, respectively.

The session also saw MUFG Americas Holdings Corp. price a new offering of bonds, though details of the sale were unavailable at press time.

More than $39 billion of new issuance has sold during a blockbuster week for high-grade bonds, blowing away expectations of a $25 billion to $30 billion week.

In the secondary market, investment-grade bond spreads eased over the session.

The Markit CDX North American Investment Grade index was 1 basis point wider at a spread of 66 basis points.

Bonds from Pfizer Inc. and Hospira, Inc. were active on Thursday following news that Pfizer would acquire Hospira for around $17 billion.

The deal will likely be financed through a combination of existing cash and new debt.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.